Triple Hair Group Enters Into Licensing Agreement with Akums for Therapy-07 in India Posted on October 23, 2024 by Pascale Bouchard […] Read More…
Triple Hair Group Receives EMA Approval to Start Phase III Clinical Trials on its Therapy-07 Prescription Drug in Europe Posted on June 19, 2024 (June 19, 2024) by Pascale Bouchard […] Read More…
Triple Hair Group Closes $4 Million Financing Posted on June 3, 2024 by Pascale Bouchard […] Read More…
Triple Hair Wins “Jury’s Choice Award” at Octane Aesthetic Tech Forum Posted on February 12, 2024 (February 12, 2024) by Pascale Bouchard […] Read More…
Triple Hair Group Signs Licensing Agreement for South Korean Market with Mother’s Pharmaceutical Posted on October 17, 2023 (February 15, 2024) by Pascale Bouchard […] Read More…
OpportunitiesNB Article on an interview with our CEO Jean-Phillipe Gravel Posted on July 27, 2023 by Pascale Bouchard […] Read More…
Triple Hair Group receives Health Canada approval to start Phase III clinical trials on its Therapy-07 prescription drug in Canada Posted on June 28, 2023 by Pascale Bouchard […] Read More…
Triple Hair Group consolidates its position as industry leader and innovator for its Therapy-07 prescription drug in the U.S. Posted on June 19, 2023 by Pascale Bouchard […] Read More…
Triple Hair Group Reports Positive Results from Safety Studies on its Therapy-07 Prescription Drug Posted on June 14, 2023 by Pascale Bouchard […] Read More…
New Possibilities in Hair Loss Prescription Therapies Posted on August 11, 2022 (August 11, 2022) by Julie-Anne Rioux […] Read More…